BioTech Health XMay 31, 2023 Biotech NewsMerck Announces Failure in Keytruda Head and Neck Cancer Phase 3 Clinical Trial 3 minute read Today Merck & Co. (NYSE: MRK) announced that Keytruda has failed the Phase 3 clinical trial KEYNOTE-412 evaluating… 0 Shares 0 0 0 0 0 0 0
BioTech Health XMay 31, 2023 Biotech NewsCel-Sci Announces Multikine Immunotherapy Significantly Improves Overall Survival Benefit for Cancer Head & Neck Patients in Phase 3 Trial 3 minute read Data Shows Significant Overall Survival Benefit for Cancer Patients with Multikine Treatment Regimen Followed by Surgery & Radiotherapy… 0 Shares 0 0 0 0 0 0 0
BioTech Health XMay 28, 2023 Biotech NewsVirios Therapeutics Stock Plunges 70% on Fibromyalgia Clinical Trial Failure Results 5 minute read In a shocking failure, Virios Therapeutics announced this morning pre-market that topline results from its FORTRESS (Fibromyalgia Outcome… 0 Shares 0 0 0 0 0 0 0
BioTech Health XMay 24, 2023 Biotech NewsCapricor Therapeutics To Present Final HOPE-2 Trial CAP-1002 Data for Late-Stage Duchenne Muscular Dystrophy (DMD) 4 minute read Capricor Therapeutics Announces HOPE-2 Trial Data Presentation On September 2nd, Capricor Therapeutics (NASDAQ: CAPR) announced an upcoming company… 0 Shares 0 0 0 0 0 0 0
Jak ThomsonMay 23, 2023 Biotech NewsMacroGenics Announces Failure in SOPHIA Study of MARGENZA for Metastatic Breast Cancer Patients 3 minute read Biopharma MacroGenics, Inc. (NASDAQ: MGNX) announced that the final overall survival (OS) analysis did not demonstrate a statistically… 0 Shares 0 0 0 0 0 0 0
BioTech Health XMay 23, 2023 Biotech NewsRecent Report Highlights Success in FDA Subgroup Approval & Treatment Arm Data 9 minute read A recent report published by the American Association for Cancer Research titled Subgroup Analyses in Oncology Trials: Regulatory… 0 Shares 0 0 0 0 0 0 0